BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34658120)

  • 1. Long noncoding RNA HAGLR sponges miR-338-3p to promote 5-Fu resistance in gastric cancer through targeting the LDHA-glycolysis pathway.
    Hu J; Huang L; Ding Q; Lv J; Chen Z
    Cell Biol Int; 2022 Feb; 46(2):173-184. PubMed ID: 34658120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
    Cui Z; Wang Q; Deng MH; Han QL
    Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
    Xu J; Xu Y; Ye G; Qiu J
    J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis.
    Sun L; Li J; Yan W; Yao Z; Wang R; Zhou X; Wu H; Zhang G; Shi T; Chen W
    Cancer Sci; 2021 Jun; 112(6):2245-2259. PubMed ID: 33756038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism.
    Ding Y; Gao S; Zheng J; Chen X
    Cancer Metab; 2022 Nov; 10(1):20. PubMed ID: 36447254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
    Shao X; Zheng X; Ma D; Liu Y; Liu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis.
    Xiang W; Zhang B; Li H
    J Chemother; 2024 Feb; 36(1):49-60. PubMed ID: 37161284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.
    Zhu L; Wang F; Fan W; Jin Z; Teng C; Zhang J
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1198-1206. PubMed ID: 34327529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
    Jin L; Luo C; Wu X; Li M; Wu S; Feng Y
    Aging (Albany NY); 2021 Aug; 13(15):19306-19316. PubMed ID: 34375306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis.
    Ni S; Liu Y; Zhong J; Shen Y
    Bioengineered; 2022 Apr; 13(4):8961-8971. PubMed ID: 35735114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA-DANCR Promotes Taxol Resistance of Prostate Cancer Cells through Modulating the miR-33b-5p-LDHA Axis.
    Wang YY; Chen C
    Dis Markers; 2022; 2022():9516774. PubMed ID: 35571619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
    Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W
    Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
    Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
    Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting lncRNA NEAT1 facilitates the sensitization of melanoma cells to cisplatin through modulating the miR-519c-3p-MeCP2 axis.
    Chen Y; Chang Y; Zhou J; Lv L; Ying H
    Pathol Res Pract; 2023 Mar; 243():154364. PubMed ID: 36841132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis.
    Gao SJ; Ren SN; Liu YT; Yan HW; Chen XB
    Mol Ther Oncolytics; 2021 Dec; 23():14-25. PubMed ID: 34589581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
    Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
    Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
    Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.